Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
11/2009
11/11/2009EP2114875A1 Substituted arylcylopentenes as therapeutic agents
11/11/2009EP1756193B1 Monomer, oligomer and pi-conjugated polymer compounds, and photovoltaic cells containing same
11/11/2009EP1709023B1 Selective estrogen receptor modulators
11/11/2009EP1575964B1 N-(benzyl)aminoalkyl carboxylate, phosphinates, phosphonates and tetrazoles as edg receptor agonists
11/11/2009EP1406870B1 Taxol enhancer compounds
11/11/2009CN101578265A Sulfonamide derivatives as chymase inhibitors
11/11/2009CN101578261A Heteroaryl-substituted serine amides
11/11/2009CN101578260A Insecticidal compounds
11/11/2009CN101575329A Preparation method of tetrahydrothiophene-3-ketone and intermediate
11/11/2009CN101575312A Substituted phenyl keto enols as pesticides and herbicides
11/11/2009CN100558724C Sulphonic acid amide for regulating bast peptide activity and derivative thereof
11/11/2009CN100558701C N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists
11/11/2009CN100558697C Cycloalkyl inhibitors of potassium channel function
11/10/2009US7615550 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis
11/05/2009WO2009132979A1 4-trimethylammonio-butyrates as cpt2 inhibitors
11/05/2009WO2009132978A1 4-dimethylaminobutyric acid derivatives
11/05/2009WO2004013122A3 Octupolar molecules used as organic semi-conductors
11/05/2009US20090275760 Process for the preparation of pure duloxetine hydrochloride
11/05/2009US20090275646 Therapeutic compounds
11/05/2009CA2722114A1 4-trimethylammonio-butyrates as cpt2 inhibitors
11/05/2009CA2722087A1 4-dimethylaminobutyric acid derivatives
11/04/2009EP2113506A2 Salts of clopidogrel and process for preparation
11/04/2009EP2113502A1 Hydrazyde type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases
11/04/2009EP1253152B1 Method of converting functional group through halogen-metal exchange reaction
11/03/2009US7612217 Sulfonium compound
11/03/2009US7612108 2-phenylthiophene derivative
11/03/2009US7612105 3-arylphenyl sulfide derivative and insecticide and miticide
11/03/2009US7611817 Aromatic sulfonium salt compound, photo-acid generator comprising the same and photopolymerizable composition containing the same, resin composition for optical three-dimensional shaping, and method of optically forming three-dimensional shape
11/03/2009CA2474510C Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
11/03/2009CA2421990C .beta.-thioamino acids
11/03/2009CA2383327C Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
11/03/2009CA2368834C Bicyclic heteroaromatic compounds useful as lh agonists
10/2009
10/29/2009WO2009132093A2 Substituted arylcyclopentenes as therapeutic agents
10/29/2009WO2009132085A1 Substituted arylcyclopentenes as prostaglandin ep2 agonists
10/29/2009WO2009131977A1 Therapeutic compounds
10/29/2009WO2009130708A2 Preparation of duloxetine and its salts
10/29/2009WO2009130475A1 Substituted thiophenecarboxamides as ikk-beta serine-, threonine-protein kinase inhibitors
10/29/2009WO2009130434A1 INHIBITORS OF IKK-β SERINE-THREONINE PROTEIN KINASE
10/29/2009WO2009130422A2 N-acylthiourea and n-acylurea inhibitors of the hedgehog protein signalling pathway
10/29/2009WO2009129915A1 Thiophene derivatives, and lc media containing the same
10/29/2009WO2009103534A3 Elansolids, novel natural metabolites of flexibacter and antibiotically active derivatives thereof
10/29/2009US20090270622 Diphosphines and Metal Complexes
10/29/2009US20090270478 Ion channel modulating activity ii
10/29/2009US20090270387 Substituted arylcyclopentenes as therapeutic agents
10/29/2009US20090270386 Therapeutic compounds
10/29/2009US20090270385 useful in treating vision defects, inflammatory bowel disease, alopecia, the stimulation of hair growth and the stimulation of the conversion of vellus hair to terminal hair
10/29/2009US20090270365 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics
10/29/2009US20090270351 Phosphorus derivatives as histone deacetylase inhibitors
10/29/2009US20090267061 Carbonyl-Functionalized Thiophene Compounds and Related Device Structures
10/29/2009DE102009015554A1 Thiophenderivate und diese enthaltende FK-Medien Thiophene derivatives and to LC media
10/29/2009CA2731279A1 Therapeutic compounds
10/29/2009CA2722660A1 Substituted thiophenecarboxamides as ikk-beta serine-, threonine-protein kinase inhibitors
10/29/2009CA2722456A1 Substituted arylcyclopentenes as prostaglandin ep2 agonists
10/29/2009CA2722403A1 Substituted arylcyclopentenes as therapeutic agents
10/29/2009CA2722258A1 N-acylthiourea and n-acylurea inhibitors of the hedgehog protein signalling pathway
10/29/2009CA2722255A1 Inhibitors of ikk-.beta. serine-threonine protein kinase
10/29/2009CA2720818A1 Substituted phenoxybenzamides
10/28/2009EP1272168B2 Small organic molecule regulators of cell proliferation
10/28/2009CN101568538A Thiophene analogues for the treatment or prevention of flavivirus infections
10/28/2009CN101568537A Method for producing C-glycoside derivative and synthetic intermediate thereof
10/28/2009CN101565435A P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
10/28/2009CN101565416A Alkynyl thiophene ketone compound and preparation method and applications thereof
10/28/2009CN101565393A 3-(substituted bisulfonyl fluromethane)-1-propylene compound, synthetic method and applications thereof
10/28/2009CN101565344A Method for preparing aldehyde or alkone by oxygen catalysis and alcohol oxidation under mild condition
10/28/2009CN100554263C Novel method of producing strontium ranelate heptahydrate
10/27/2009US7608721 2-{4-[Ethyl-(thiazol-4-ylmethyl)-amino]-phenyl}-1,1,1,3,3,3-hexafluoro-propan-2-ol; liver-X-receptor modulators; anticholesterol agents; antiinflammatory agents; atherosclerosis; dyslipidemia; antidiabetic agents; alzheimer's disease; sepsis; skin disorders; cognition modulators
10/27/2009US7608631 1-(4-{3-[2,6-Dichloro-4-(3,3-dichloro-allyloxy)-phenoxy]-propoxy}-phenyl)-1H-pyrrole, for example; protecting soybean plants against pests such as caterpillars
10/27/2009CA2415966C Tetrahydro-heterocycloazepinyl pyrimidine derivatives
10/27/2009CA2381885C Isomeric fused pyrrolocarbazoles and isoindolones
10/27/2009CA2376355C N-heterocyclic derivatives as nos inhibitors
10/22/2009WO2009128558A1 Activator for peroxisome proliferator-activated receptor
10/22/2009WO2009128521A1 Cysteine protease inhibitor
10/22/2009US20090264663 3-HYDROXYMETHYLBENZO[b]THIOPHENE DERIVATIVES AND PROCESS FOR THEIR PRODUCTION
10/22/2009US20090264474 Sulfonamides as trpm8 modulators
10/22/2009US20090264411 Fused thiophene derivatives as mek inhibitors
10/22/2009US20090261300 Heteroacene derivative, tetrahaloterphenyl derivative, and processes for producing the same
10/22/2009CA2721371A1 Small molecule inhibitors of the pleckstrin homology domain and methods for using same
10/22/2009CA2721339A1 Activating agent for peroxisome proliferator activated receptor
10/21/2009EP1904471B1 Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents
10/21/2009EP1381366B9 Indole, azaindole and related heterocyclic amidopiperazine derivatives
10/21/2009CN101560202A Preparation method of 2-(2-thienyl) ethyl-4-methylbenzenesulfonate
10/21/2009CN101560158A Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/21/2009CN101560136A Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/21/2009CN100551922C Method for preparing photochromic 1-thiophene2-phenyl six-membered ring series-parallel asymmetric perfluoro cyclopentene and use thereof
10/20/2009US7605261 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
10/20/2009US7605259 Structurally rigid dopamine d3 receptor selective ligands and process for making them
10/20/2009US7605164 Compositions and methods for treating heart failure
10/20/2009US7605111 Herbicides
10/20/2009US7604874 having an anthracene compound substituted with at least one thiophenyl ring; OLED organic light emitters; as displays with low power consumption, faster response time, higher brightness level, unlimited viewing angle
10/20/2009CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection
10/20/2009CA2314685C A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene hydrochloride
10/15/2009WO2009125861A1 Cysteine protease inhibitor
10/15/2009WO2009125704A1 Compound for organic thin-film transistor and organic thin-film transistor using the compound
10/15/2009WO2009124962A2 Sulfonamides
10/15/2009WO2009085344A3 Dibenzothiophene, dibenzofuran and/or carbazole-containing materials in phosphorescent light emitting diodes
10/15/2009US20090259053 Process for brominating alkylthiophenes
10/15/2009US20090258936 Cxcr2 inhibitors
10/15/2009US20090258912 N-(1-Alkyl-2-Phenylethyl)-Carboxamide Derivatives and Use Thereof as Fungicides
10/15/2009US20090258906 Cxcr2 antagonists
10/15/2009DE102008018485A1 Verfahren zur Bromierung von Alkylthiophenen A process for the bromination of alkyl thiophenes
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 329